We are live on
!
Find out more
JGUA
John G. Ullman & Associates Portfolio holdings
AUM
$754M
1-Year Est. Return
60.05%
This Fund
S&P 500
This Quarter
Est. Return
+5.6%
1 Year Est. Return
+60.05%
3 Year Est. Return
+108.28%
5 Year Est. Return
+118.76%
10 Year Est. Return
+308.24%
AUM
$487M
AUM Growth
+$60.8M
(+14%)
Cap. Flow
+$38.3M
Cap. Flow
% of AUM
7.87%
Top 10 Holdings %
Top 10 Hldgs %
34.77%
Holding
122
New
17
Increased
29
Reduced
59
Closed
5
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
TE Connectivity
TEL
|
+$7.16M |
| 2 |
Abbott
ABT
|
+$4.51M |
| 3 |
Duke Energy
DUK
|
+$3.52M |
| 4 |
State Street SPDR S&P Biotech ETF
XBI
|
+$3.16M |
| 5 |
SCG
Scana
SCG
|
+$2.45M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Booking.com
BKNG
|
+$2.45M |
| 2 |
BXLT
BAXALTA INC COM STK (DE)
BXLT
|
+$2.24M |
| 3 |
Johnson & Johnson
JNJ
|
+$1.46M |
| 4 |
GSK
GSK
|
+$497K |
| 5 |
Applied Materials
AMAT
|
+$423K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 27.69% |
| 2 | Industrials | 18.44% |
| 3 | Technology | 17.48% |
| 4 | Utilities | 8.95% |
| 5 | Energy | 8.11% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
101
Cigna
CI
$77.1B
| $307K | 0.06% |
+2,400
| New | +$317K |
|
102
Danaher
DHR
$137B
| $252K | 0.05% |
+3,720
| New | +$243K |
|
103
Community Bank
CBU
$3.52B
| $241K | 0.05% |
5,864
| – | – |
|
104
Paychex
PAYX
$41.2B
| $228K | 0.05% |
3,825
| – | – |
|
105
Verizon
VZ
$198B
| $220K | 0.05% |
3,937
-191
| -5% | -$9.91K |
|
106
PepsiCo
PEP
$191B
| $219K | 0.05% |
2,070
| – | – |
|
107
NiSource
NI
$22B
| $215K | 0.04% |
+8,100
| New | +$194K |
|
|
IXYS
108
DELISTED
IXYS Corp
IXYS
| $130K | 0.03% |
12,700
-3,600
| -22% | -$39.2K |
|
|
NSLR
109
Neostellar Capital Corp
NSLR
$269M
| $61K | 0.01% |
+14,414
| New | +$65.3K |
|
110
Hecla Mining
HL
$10.2B
| $52K | 0.01% |
+10,224
| New | +$41.3K |
|
111
Advanced Micro Devices
AMD
$804B
| $51K | 0.01% |
10,000
| – | – |
|
|
SVU
112
DELISTED
SUPERVALU Inc.
SVU
| $47K | 0.01% |
1,429
| – | – |
|
|
EVRI
113
DELISTED
Everi Holdings
EVRI
| $16K | ﹤0.01% |
+14,000
| New | +$23.3K |
|
|
114
Booking.com
BKNG
$145B
| – | – |
-47,500
| Closed | -$2.45M |
|
115
Precigen
PGEN
$1.96B
| – | – |
-6,054
| Closed | -$203K |
|
116
Portland General Electric
POR
$5.96B
| – | – |
-5,860
| Closed | -$231K |
|
|
PPL
117
PPL Corp
PPL
$27.1B
| – | – |
-5,500
| Closed | -$209K |
|
|
BXLT
118
DELISTED
BAXALTA INC COM STK (DE)
BXLT
| – | – |
-55,372
| Closed | -$2.24M |
|
|
EAG
119
DELISTED
AMERICAN DEFENSE SYS INC COM STK (DE)
EAG
| $0 | ﹤0.01% |
50,000
| – | – |
|
Similar funds
HCM
FSCM
SF
RMC
BEC
GFM
TPW
MWA
John G. Ullman & Associates's Q2 2016 Portfolio in Review
As of Q2 2016, John G. Ullman & Associates held 122 positions worth $487M, up 14% from $426M the previous quarter. Its ten largest holdings account for 35% of the portfolio.
John G. Ullman & Associates deployed $38.3M of net new capital in Q2 2016, opening 17 new positions and adding to 29 existing holdings. Its largest new stake was State Street SPDR S&P Biotech ETF: 57,720 shares worth $3.12M.
By sector, the portfolio is most concentrated in Healthcare at 28% of assets, up from 27% a quarter earlier, followed by Industrials and Technology.
On the sell side, the largest reduction was Johnson & Johnson, an estimated $1.46M trimmed.
- John G. Ullman & Associates's largest Q2 2016 buy was State Street SPDR S&P Biotech ETF: 57,720 shares worth $3.12M.
- John G. Ullman & Associates added most to TE Connectivity in Q2 2016, an estimated $7.16M increase.
- John G. Ullman & Associates's biggest Q2 2016 reduction was Johnson & Johnson, cutting an estimated $1.46M.
- John G. Ullman & Associates fully exited Booking.com in Q2 2016, selling an estimated $2.45M.
- John G. Ullman & Associates's ten largest holdings make up 35% of its $487M portfolio in Q2 2016.
- John G. Ullman & Associates opened 17 new positions and closed 5 in Q2 2016.
- John G. Ullman & Associates's portfolio value rose 14% quarter-over-quarter to $487M.
Based on John G. Ullman & Associates's 13F filing for Q2 2016, filed 22 Jul 2016.